Header Logo

Connection

ANITA DESWAL to Obesity

Back to Details
This is a "connection" page, showing publications ANITA DESWAL has written about Obesity.
ANITA DESWAL
Connection Strength
2.172
Obesity
  1. THE OBESITY PARADOX IN HEART FAILURE: TIME TO MOVE FORWARD. Trans Am Clin Climatol Assoc. 2025; 135:43-51.
    View in: PubMed
    Score: 0.387
  2. Obesity and Heart Failure with Preserved Ejection Fraction. Heart Fail Clin. 2021 Jul; 17(3):345-356.
    View in: PubMed
    Score: 0.303
  3. Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction. Int J Obes (Lond). 2020 07; 44(7):1561-1567.
    View in: PubMed
    Score: 0.281
  4. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. JACC Heart Fail. 2017 01; 5(1):56-63.
    View in: PubMed
    Score: 0.222
  5. Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker? Curr Atheroscler Rep. 2016 May; 18(5):21.
    View in: PubMed
    Score: 0.212
  6. Obesity, leptin, and incident heart failure. J Am Coll Cardiol. 2011 Oct 25; 58(18):1878-80.
    View in: PubMed
    Score: 0.155
  7. Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J. 2005 Dec; 150(6):1233-9.
    View in: PubMed
    Score: 0.103
  8. In adults with overweight or obesity and CVD, but without diabetes, semaglutide reduced MACE at a mean 40 mo. Ann Intern Med. 2024 03; 177(3):JC31.
    View in: PubMed
    Score: 0.091
  9. In patients with HFpEF and obesity, semaglutide increased weight loss and reduced symptoms and physical limitations at 52 wk. Ann Intern Med. 2023 12; 176(12):JC136.
    View in: PubMed
    Score: 0.090
  10. Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee. J Card Fail. 2019 May; 25(5):380-400.
    View in: PubMed
    Score: 0.065
  11. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817.
    View in: PubMed
    Score: 0.064
  12. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016 12 06; 134(23):e535-e578.
    View in: PubMed
    Score: 0.055
  13. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2016 Feb 16; 133(7):631-8.
    View in: PubMed
    Score: 0.052
  14. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol. 2014 Dec 30; 64(25):2743-9.
    View in: PubMed
    Score: 0.048
  15. The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study. Am J Epidemiol. 2010 Oct 01; 172(7):781-9.
    View in: PubMed
    Score: 0.036
  16. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol. 2010 Feb 01; 105(3):373-7.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.